Research / Stocks / BC BC NYSE CIK 0000014930
BRUNSWICK CORP · Engines & Turbines
RESEARCH CURRENTCOVERAGE / STANDARD
Latest filing 4 · Aug 20, 2026
Research state Latest filing analysis is current
Last SEC check Sep 13, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT BRUNSWICK CORP's latest supported as-filed period reports revenue of $1.6B . Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Debt relative to revenue RAW Current state valid · history insufficient
Method Level · gp.fundamentals.debt_to_revenue
Raw value 134.86% · OPTIONAL
Capex intensity RAW Current state valid · history insufficient
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.66% · OPTIONAL
Operating cash generation RAW Current state valid · history insufficient
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 20.14% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value 7.66% · CORE
Inventory pressure RAW Current state valid · history insufficient
Method Level · gp.fundamentals.inventory_revenue_ratio
Raw value 78.12% · OPTIONAL
Operating margin RAW Current state valid · history insufficient
Method Level · gp.fundamentals.operating_margin
Raw value 8.31% · CORE
R&D intensity RAW Current state valid · history insufficient
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jul 4, 2026 General Corporate
Governance Evidence 3 evidence-backed dimensions Filing Amendments None Detected Auditor Changes None Detected Insider Activity Observed [email protected] · 3 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Cash Generation
BC 20.1
Peer median 11.2
Peer percentile 73th 97 valid peers · 83% coverage · +0.6 robust σ Capex Intensity
BC 2.7
Peer median 2.2
Peer percentile 65th 84 valid peers · 72% coverage · +0.4 robust σ Inventory Pressure
BC 78.1
Peer median 71.2
Peer percentile 59th 100 valid peers · 85% coverage · +0.2 robust σ Growth
BC 7.7
Peer median 10.3
Peer percentile 42th 99 valid peers · 85% coverage · -0.2 robust σ Profitability
BC 8.3
Peer median 10.2
Peer percentile 44th 99 valid peers · 85% coverage · -0.1 robust σ Open group breadth → Divergence is context, not positive or negative. INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 0
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0000014930-26-000110 11 governed changes · top 7 shown
01
INFORMATIONAL IMPORTANCE Capex 33TH HISTORICAL PCTL · N=3
Capex / revenue moved 45 bp lower Capex / revenue changed -45 basis points from the comparable as-filed period.
Why this ranks here · [email protected] 3.10% → 2.66% Comparable → current
02
LOW IMPORTANCE Capex 33TH HISTORICAL PCTL · N=3
Capital expenditure decreased 7.8% Capital expenditure changed -7.8% from the comparable as-filed period.
Why this ranks here · [email protected] $44.9M → $41.4M Comparable → current
03
LOW IMPORTANCE Cash 50TH HISTORICAL PCTL · N=2
Cash & equivalents decreased 8.7% Cash & equivalents changed -8.7% from the comparable as-filed period.
Why this ranks here · [email protected] $315.7M → $288.1M Comparable → current
04
HIGH IMPORTANCE Debt 100TH HISTORICAL PCTL · N=4
Debt increased 67.2% Debt changed +67.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 2.66% +0.0% ↑ Capital expenditure $41.4M -27.6% ↓ Cash & equivalents $288.1M +0.0% ↑ Debt $295.2M -39.8% ↓ Free-cash-flow proxy $272.4M +324.6% ↑ Gross margin 27.90% +2.3% ↑ Interest expense $24.8M +0.8% ↑ Inventory $1.2B -2.9% ↓
ACTIVE TRACE Revenue BC · as filed with the SEC · reported-date aware
PASS · 24 OBS
Capex / revenue Q2 / 2026-07-04 2.66% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q2 / 2026-07-04 $41.4M -27.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q2 / 2026-07-04 $288.1M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Debt Q2 / 2026-07-04 $295.2M -39.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q2 / 2026-07-04 $272.4M +324.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin FY / 2020-12-31 27.90% +2.3% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest expense Q2 / 2026-07-04 $24.8M +0.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory Q2 / 2026-07-04 $1.2B -2.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q2 / 2026-07-04 $109.8M +422.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q2 / 2026-07-04 $313.8M +589.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q2 / 2026-07-04 8.31% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q2 / 2026-07-04 $50.4M +8.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
4 Aug 20, 2026 Period Aug 19, 2026 0001828441-26-000002SEC ↗ 4 Aug 20, 2026 Period Aug 19, 2026 0001667218-26-000002SEC ↗ 10-Q Aug 5, 2026 Period Jul 4, 2026 0000014930-26-000110SEC ↗ 4 Aug 3, 2026 Period Jul 31, 2026 0000014930-26-000106SEC ↗ 4 Aug 3, 2026 Period Jul 31, 2026 0000014930-26-000105SEC ↗ 4 Aug 3, 2026 Period Jul 31, 2026 0000014930-26-000104SEC ↗ 4 Aug 3, 2026 Period Jul 31, 2026 0000014930-26-000103SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗